Search
Now showing items 1211-1220 of 1253
Azacitidine for front-line therapy of patients with AML: reproducible efficacy established by direct comparison of international phase 3 trial data with registry data from the Austrian azacitidine registry of the AGMT study group
Pleyer, Lisa et al. (2017)
Wissenschaftlicher Artikel
Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): Comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line
Bentz, M et al. (2001)
Wissenschaftlicher Artikel
Ivosidenib and Azacitidine in IDH1-Mutated AML REPLY
Montesinos, Pau; de Botton, Stephane; Döhner, Hartmut (2022)
Wissenschaftlicher Artikel
Longitudinal single-cell transcriptomics reveals distinct patterns of recurrence in acute myeloid leukemia
Zhai, Yanan et al. (2022)
Wissenschaftlicher Artikel
Unified classification and risk-stratification in Acute Myeloid Leukemia
Tazi, Yanis et al. (2022)
Wissenschaftlicher Artikel
Modeling the B-cell receptor signaling on single cell level reveals a stable network circuit topology between nonmalignant B cells and chronic lymphocytic leukemia cells and between untreated cells and cells treated with kinase inhibitors
Wolf, Christine et al. (2022)
Wissenschaftlicher Artikel
Prognostic impact of NPM1 and FLT3 mutations in patients with AML in first remission treated with oral azacitidine
Döhner, Hartmut et al. (2022)
Wissenschaftlicher Artikel
Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence
Duy, Cihangir et al. (2021)
Wissenschaftlicher Artikel
RUNX1 mutations in acute myeloid leukemia
Teleanu, Maria-Veronica (2017)
Dissertation
Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax
Tausch, Eugen et al. (2020)
Wissenschaftlicher Artikel